Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 14, 2016 2:19 PM ET

Personal Products

Company Overview of KeyView Labs, Inc.

Company Overview

KeyView Labs, Inc. researches, develops, and tests brain health and fitness supplements. It offers Procera AVH, a nutritional supplement for forgetfulness, fuzzy focus, mood swings, and mental fatigue brought on by stress, sleep loss, poor diet, and aging. The company also offers Ceraplex, a natural, multi-action brain anti-oxidant, detoxification, and neuro-protective formula to protect the brain against the daily onslaught of a spectrum of toxins and stressors, including free radicals, stress hormones, and aging; and boosts brainpower by increasing brain blood flow, oxygen, glucose, and key neuro-transmitters to the brain. In addition, it offers TriOmega DHA, a formulation for improving ce...

5737 Benjamin Center Drive

Tampa, FL 33634-5239

United States

Founded in 2005



Key Executives for KeyView Labs, Inc.

Chief Executive Officer and Director
Executive Director
Executive Director
Compensation as of Fiscal Year 2015.

KeyView Labs, Inc. Key Developments

KeyView Labs Inc.'s Procera AVH® Earns Memory Claim Approval from Health Canada

Health Canada has expanded its claim approval for KeyView Labs Inc.'s Procera AVH® to include that the supplement "helps support brain function and cognitive health, including mood and memory. The agency's approval is a key step in the regulatory process for licensed natural health products in Canada, which will ultimately result in Procera AVH being available for sale throughout the country. Currently, Procera AVH, a non-prescription nutritional supplement that supports brain health and cognitive function, is available in nearly 23,500 stores in the United States, where it has been used more than 100 million times since its launch over a decade ago. Procera AVH's patented, triple-action formula supports brain health and cognitive function by promoting blood flow, supporting vital neurotransmitters and providing a layer of protection. Its three primary ingredients are: Acetyl-l-carnitine, a natural ingredient, which provides neurotransmitter support essential to brain function; Vinpocetine, derived from natural plant extracts, which enhances blood flow to the brain; Huperzine A, a natural ingredient extracted from a plant, helps support Acetylcholine and provides antioxidant support for the brain.

Similar Private Companies By Industry

Company Name Region
CuraTech Industries, Inc. United States
Hero Nutritionals Inc. United States
BioGeron, Inc. United States
Tyco Healthcare Retail Group, Inc. United States
MET-Rx Nutrition Inc. United States

Recent Private Companies Transactions

Private Placement
May 20, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact KeyView Labs, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at